Magnifying endoscopic assessment for mucosal healing by leukocytoapheresis in ulcerative colitis patients

Magnifying endoscopic assessment for mucosal healing by leukocytoapheresis in ulcerative colitis patients - Magnifying endoscopy, leukocytoapheresis and ulcerative colitis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016017

Enrollment

Registered

2015-01-01

Start date

2015-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Ulcerative colitis patients treated by LCAP in whom informed consent was obtained to enroll in this study

Exclusion criteria

Exclusion criteria: severe concomitant diseases such as liver, kidney and heart diseases prengnant or lactating cases patients prescribed with ACE inhibitors unsuitable patients judged by responsible persons

Design outcomes

Primary

Measure	Time frame
To evaluate clinical course of ulcerative colitis with magnifying endoscopic findings change of mucosal healing before and after LCAP	—

Secondary

Measure	Time frame
remission period, endoscopic findings, and severity in ulcerative colitis	—

Countries

Japan

Contacts

Public ContactHajime Isomoto

Nagasaki University Hospital Endoscopy

hajimei2002@yahoo.co.jp095-819-7336

Outcome results